Israeli firm ready to assist coronavirus victims with novel drug – The innovative therapy is based on the research of Prof. Dror Mevorach, a senior physician from Hadassah-Hebrew University Hospital. | The Jerusalem Post
A clinical-stage Israeli immunotherapy company – specializing in drug development for sepsis and organ dysfunction – is “ready to assist” health authorities combating deadly complications caused by the novel coronavirus.
Oliver Benjamin Hemmerle
Und die Mullahs enthalten es dann im Zweifelsfall ihrer Bevölkerung vor!